台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效

易威

(1799)
  • 股價
    56.7
  • 漲跌
    ▲0.2
  • 漲幅
    +0.35%
  • 成交量
    127
  • 產業
    上櫃 生技醫療類股
  • 72人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2025/04/17 ~ 2025/04/24     後一日»

券商獲利排行 - 2025/04/17 ~ 2025/04/24

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.01%69.7069.7-6006057.9057.956.7
  2.11%67.21.565.7-5315557.956.457.956.7
  3.49%61.19.152-2733058.455.658.656.7
  3.08%43.28.334.9-1862458.457.358.656.7
  1.10%32-9.241.2-31195058.258.55856.7
  3.55%25223-1111258.656.858.856.7
  3.90%23023-100105905956.7
  4.88%20.23.117.1-61759.256.559.656.7
  3.28%15.4015.4-80858.6058.656.7
  1.85%15.113.12-1131458.257.758.756.7
  4.14%14.7014.7-60659.2059.256.7
  1.43%14.31.712.6-6111758.758.658.856.7
  0.38%13.616.3-2.79635457.15757.356.7
  1.26%13.1-1.714.8-1621857.758.557.656.7
  3.90%11.5011.5-5055905956.7
  1.27%1113.8-2.8915657.75759.356.7
  5.35%9.39.3003357.756.259.356.7
  1.75%9.10.88.2-81957.656.957.756.7
  2.85%8.28.2005557.656.758.356.7
  3.68%6.506.5-20358.85658.956.7
  1.61%6.306.377055.855.8056.7
  3.57%6.306.3-30358.8058.856.7
  0.35%6063030056.556.5056.7
  2.16%60655055.555.5056.7
  2.60%62.93.1-22457.856.858.356.7
  1.60%5.62.53.1-1465857.658.256.7
  4.55%5.405.4-20259.4059.456.7
  3.08%5.405.4-30358.5058.556.7
  1.80%50555055.755.7056.7
  4.22%505-20259.2059.256.7
  2.80%4.904.9-20358.358.458.356.7
  4.12%4.82.42.4-11258.356.759.156.7
  0.45%4.66.6-27181157.25757.656.7
  3.80%4.504.5-10259.2625956.7
  1.94%4.504.5-3045858.857.856.7
  3.65%4.304.3-10258.959.158.956.7
  2.44%4.304.3-30358.1058.156.7
  2.43%4.204.2-30358.156.658.156.7
  3.57%4.204.2-20258.8058.856.7
  3.57%4.12.51.6-11257.555.858.356.7
  0.34%45.5-1.51201958.458.258.556.7
  1.13%4-0.14.1-24658.858.858.856.7
  0.99%3.903.977056.156.1056.7
  1.70%3.93.9004457.256.757.756.7
  3.08%3.603.6-20258.5058.556.7
  2.02%3.503.5-30357.9057.956.7
  1.22%3.403.45505656056.7
  2.94%3.41.71.7-11257.856.758.456.7
  5.72%3.33.3001157.75659.356.7
  2.60%33002258.557.759.356.7

券商虧損排行 - 2025/04/17 ~ 2025/04/24

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -3.17%-74.30-74.34040058.658.6056.7
  -2.75%-65.90.4-66.34041158.458.458.856.7
  -2.47%-47.90-47.9-3503555.3055.356.7
  -1.63%-39.61.2-40.83742557.857.85856.7
  -3.66%-36.60-36.61717058.958.9056.7
  -4.04%-310-311313059.159.1056.7
  -4.42%-25.6-25.600101057.959.256.656.7
  -2.58%-24-1.5-22.51416258.258.357.656.7
  -3.07%-21.4-3.9-17.51012258.258.556.556.7
  -2.17%-18.90-18.9151505858056.7
  -3.11%-14.6-0.7-13.978158.658.75856.7
  -4.71%-140-1455059.559.5056.7
  -1.91%-12.2-1.4-10.881135858.157.656.7
  -3.14%-10.8-10-0.8-24657.358.856.356.7
  -2.82%-9.9-9.9006658.559.457.756.7
  -1.79%-9.3-0.9-8.489157.757.856.956.7
  -2.20%-8.9-1.1-7.867157.95856.956.7
  -3.43%-7.8-6.2-1.6-22456.95955.956.7
  -4.38%-7.80-7.833059.359.3056.7
  -3.16%-7.3-7.3004457.758.656.856.7
  -3.74%-6.60-6.633058.958.9056.7
  -0.86%-6.30-6.3-1301356.2056.256.7
  -0.46%-6.1-0.7-5.44231958585856.7
  -0.48%-6-10.24.2-1662257.358.75756.7
  -1.25%-5.7-5.2-0.6-4485757.956.656.7
  -1.86%-5.3-4.9-0.4-23557.158.156.556.7
  -3.02%-5.30-5.333058.558.5056.7
  -3.00%-5.3-5.3003358.359.257.556.7
  -4.22%-50-522059.259.2056.7
  -4.22%-50-522059.259.2056.7
  -4.20%-4.9-2.5-2.412158.359.156.656.7
  -1.07%-4.90-4.978057.357.358.956.7
  -2.66%-4.7-0.3-4.423158.858.958.656.7
  -3.90%-4.60-4.62205959056.7
  -1.34%-4.50-4.5-51655.855.855.856.7
  -1.71%-41-534158.658.459.456.7
  -1.40%-4-1.4-2.645157.157.45656.7
  -0.76%-3.90-3.999057.157.1056.7
  -6.59%-3.8-3.8001157.759.655.856.7
  -3.24%-3.80-3.822058.658.6056.7
  -2.19%-3.80-3.83305858056.7
  -2.19%-3.80-3.823057.8585656.7
  -1.61%-3.70-3.744057.657.6056.7
  -3.08%-3.60-3.622058.558.5056.7
  -2.91%-3.40-3.422058.458.4056.7
  -5.73%-3.3-3.3001157.659.255.956.7
  -2.74%-3.20-3.222058.358.3056.7
  -0.35%-30-3-1501556.5056.556.7
  -1.07%-30-3-50556.1056.156.7
  -4.65%-2.7-2.7001158.159.456.756.7
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音